New laser treatment could stop blindness before it starts

Original Source: This article is based on reporting by Science Daily β†’

πŸ“° Source: sciencedaily.com

This is a curated summary with editorial analysis. Click source for full article.

πŸ“Š Healthcare News Analysis: Our editorial team has analyzed recent developments from sciencedaily.com in the Healthcare sector. This report covers key insights related to medical treatment, surgery, prescription and emerging industry trends that professionals should monitor closely.

The Healthcare landscape is evolving, with recent reports indicating notable changes. Roughly one in three people over the age of 80 experiences age-related macular degeneration (AMD), a condition that affects the retina and leads to central vision loss. Data shows that in the United States, about 20 million adults aged 40 and older are currently living with AMD.

The vast majority have the “dry” form, which develops gradually and eventually causes difficulty seeing objects directly in front of them. Despite being one of the most common causes of vision impairment among older adults, there is still no effective treatment for dry AMD. Researchers at Aalto University have identified a promising new way to slow or even halt the early stages of dry AMD.

Their approach focuses on reinforcing the natural defense systems of retinal cells by applying controlled heat, according to Professor Ari Koskelainen. “Cellular functionality and protective mechanisms weaken with age, which exposes the fundus [the inside surface at the back of the eye] to intense oxidative stress,” Koskelainen explains. “Free oxygen radicals damage proteins, which causes them to misfold and aggregate, then fatty protein deposits called drusen begin to accumulate, which is the main diagnostic criterion for the dry form of age-related macular degeneration.”
Using Heat to Trigger the Eye’s Repair Response
The treatment involves carefully warming the affected tissue by several degrees, a challenging task because it is difficult to measure temperature behind the retina. According to reports that temperatures above 45 degrees Celsius can damage tissue, but the Aalto team developed a method that allows real-time temperature monitoring while heating the area with near infrared light.

Sources indicate that this enables safe, precise control while using heat to activate the eye’s natural healing responses at a cellular level. Sources indicate that when proteins inside the eye misfold, cells can respond in several ways. One mechanism involves heat shock proteins, which are produced in response to stress and can help refold damaged proteins into their original structure. According to reports that if that process fails, the faulty proteins are targeted for breakdown into amino acids so they can be recycled.

If protein build-up has already occurred, another mechanism called autophagy takes over. This process, discovered by Nobel laureate Yoshinori Ohsumi in 2016, encloses the accumulation within a lipid membrane similar to a cell membrane. Recognition proteins on the membrane’s surface then signal lysosomal enzymes to begin breaking down and removing damaged material. Sources indicate that “We were able to show that we can activate not only the production of the heat shock proteins, but also autophagy using the heat shocks.

This process is like waste disposal,” says Koskelainen. Promising Results and Next Steps
The new technique has already produced positive results in animal studies involving mice and pigs. Human clinical trials are scheduled to begin in Finland in the spring of 2026. The first phase will focus on confirming the safety of the laser treatment before moving on to determine how frequently it should be repeated for lasting results.

According to reports that “The treatment needs to be repetitive, since the response can already begin to decline some days after the treatment,” Koskelainen says. The findings were published in Nature Communications on October 29. Data shows that the research team has also launched a spin-off company, Maculaser, to help bring the therapy to clinical use.

“An optimistic schedule would see the method already being used in hospital eye clinics in as little as three years’ time,” Koskelainen adds. “The eventual goal is that it would be readily available at your local ophthalmologist.”
Story Source:
Materials provided by Aalto University. Data shows that note: Content may be edited for style and length.

Evidence suggests that journal Reference:
Cite This Page:
The Surprising Brain Exercise That Reverses Aging
Gray Hair May Be Your Body’s Secret Cancer Defense
Obesity Discovery Stuns Scientists, Challenges 60-Year-Old Beliefs
NASA Finds Hidden Heat on Saturn’s Icy Moon Enceladus, Hinting at Life

Experts suggest this represents a significant moment for the Healthcare sector, with implications extending beyond immediate stakeholders.

β€” Based on reporting from sciencedaily.com

πŸ’‘ Key Industry Insights

The focus on preventive care and patient outcomes continues to drive industry transformation.

Specifically regarding surgery, market observers note continuing evolution in service delivery, pricing models, and customer engagement strategies that merit close attention from industry stakeholders.

Market Impact: These developments in medical treatment may significantly influence market dynamics. Industry experts recommend monitoring these trends closely for strategic planning purposes.

Analysis Note: This comprehensive overview synthesizes current market intelligence from sciencedaily.com regarding surgery and related sectors. Stay informed about ongoing developments in this rapidly evolving landscape.

πŸ“– Read Full Article at Source

Get the complete story with all details from sciencedaily.com

Continue Reading β†’